lormetazepam

01/01/2007 - "In this open-label study, 30 elderly outpatients with insomnia were randomised to receive 2 weeks of treatment with lormetazepam 0.5mg + SHT or SHT alone, followed by a 1-week observation period. "
01/01/2007 - "This study was performed to evaluate the efficacy and safety of lormetazepam in elderly patients with primary insomnia when used in association with sleep hygiene training (SHT). "
11/01/1982 - "Dose-response studies of lormetazepam: efficacy, side effects, and rebound insomnia."
01/01/2007 - "No rebound insomnia was reported during follow-up in patients in the lormetazepam group. "
01/01/2007 - "Role of lormetazepam in the treatment of insomnia in the elderly."

05/29/1981 - "[Lormetazepam in the treatment of sleep disorders in a medical practice; double-blind test on 100 patients (author's transl)]."
08/31/1981 - "[Comparison of lormetazepam, flunitrazepam and placebo in a long-term effect and long-term tolerance study in 105 patients with chronic sleep disorders]."
05/29/1981 - "Lormetazepam (1 mg) and diazepam (5 mg) were compared in a double-blind study of 100 patients with sleep disorders associated with a medical illness. "
09/01/2002 - "In order to test the hypothesis that sedating antidepressants are useful in the treatment of primary insomnia, the effect of trimipramine on objectively and subjectively measured parameters of sleep was investigated in a double-blind placebo- and lormetazepam-controlled study in a sample of 55 patients with primary insomnia attending outpatient sleep-disorder clinics. "

01/01/2014 - "Intravenous Lormetazepam during Sedation Weaning in a 26-Year-Old Critically Ill Woman."
09/10/2021 - "Thus, we concluded that excessive sedation occurs more frequently in critically ill patients treated with midazolam than in patients treated with lormetazepam. "
09/10/2021 - "Outcomes in Critically Ill Patients Sedated with Intravenous Lormetazepam or Midazolam: A Retrospective Cohort Study."
01/01/2022 - "Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID-19-Associated Acute Respiratory Distress Syndrome."

05/01/1989 - "Both drugs improved sleep, but compared with placebo or lormetazepam-takers, triazolam-takers became more anxious on self-ratings, were judged more often to have had a bad response by an observer, more often wrote down complaints of distress, and suffered weight loss. "

01/01/2022 - "Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID-19-Associated Acute Respiratory Distress Syndrome."